Answers are grounded in this paper and cite their sources.
Tumor-naïve detection of ctDNA by multimodal profiling may facilitate biomarker discovery and clinical use in low ctDNA abundance applications.
No takes yet. Share an insight, caveat, or question.
Burgener et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: